Legionellosis in a bone marrow transplant center

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 361-368

  Harrington, R D ^a,b   Woolfrey, A E ^a,b   Bowden, R ^a,b   McDowell, M G ^c   Hackman, R C ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Washington State Public Health Laboratory   (United States)

Author keywords

Bone marrow transplant; Legionella

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HUMAN TISSUE; LEGIONELLA; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MALE; PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HUMANS; LEGIONELLOSIS; MALE; MIDDLE AGED;

EID: 0029836232     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Horwitz MA. Cell-mediated immunity in Legionnaires' disease. J Clin Invest 1983; 71: 1686-1697.
2. Nguyen MH, Stout JE, Yu VL. Legionellosis. Infect Dis Clin N Am 1991; 5: 561-584.
3. Fraser DW, Tsai TR, Orenstein W et al. Legionnaires' disease: description of an epidemic of pneumonia. New Engl J Med 1977; 297: 1189-1197.
4. Bock BV, Kirby BD, Edelstein PH et al. Legionnaires' disease in renal-transplant recipients. Lancet 1978; 1: 410-413.
5. Beaty HN, Miller AA, Broome CV et al. Legionnaires' disease in Vermont, May to October 1977. JAMA 1978; 240: 127-131.
6. Myerowitz RL, Pasculle AW, Dowling JN et al. Opportunistic lung infection due to 'Pittsburgh pneumonia agent'. New Engl J Med 1979; 301: 953-958.
7. Kirby BD, Snyder KM, Meyer RD, Finegold SM. Legionnaires' disease: report of sixty-five nosocomially acquired cases and review of the literature. Medicine 1980; 59: 188-205.
8. England AC, Fraser DW, Plikaytis BD et al. Sporadic Legionellosis in the United States: the first thousand cases. Ann Intent Med 1981; 94: 164-170.
9. Kugler JW, Armitage JO, Helms CM et al. Nosocomial Legionnaires' disease: occurrence in recipients of bone marrow transplants. Am J Med 1983; 74: 281-288.
10. Dowling JN, Pasculle AW, Frola FN et al. Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant patients. J Infect Dis 1984; 149: 703-713.
11. Rudin JE, Wing EJ. A comparative study of Legionella micdadei and other nosocomial acquired pneumonia. Chest 1984; 86: 675-680.
12. Parry MF, Stampleman L, Hutchinson JH et al. Waterborne Legionella Bozemanii and nosocomial pneumonia in immunosuppressed patients. Ann Intern Med 1985; 103: 205-210.
13. Meletis J, Arlet G, Dournon E et al. Legionnaires' disease after bone marrow transplantation. Bone Marrow Transplant 1987; 2: 307-313.
14. Ampel NM, Wing EJ, Legionella infection in transplant patients. Semin Resp Infect 1990; 5: 30-37.
15. Bangsborg JM, Jensen BN, Friis-Møller, Bruun B. Legionellosis in patients with HIV infection. Infection 1990; 18: 342-346.
16. Horbach I, Fehrenbach FJ. Legionellosis in heart transplant recipients. Infection 1990; 18: 361-363.
17. Schwebke JR, Hackman R, Bowden R. Pneumonia due to Legionella micdadei in bone marrow transplant recipients. Rev Infect Dis 1990; 12: 824-828.
18. Benz-Lemoine E, Delwail V, Castel O et al. Nosocomial Legionnaires' disease in a bone marrow transplant unit. Bone Marrow Transplant 1991; 7: 61-63.
19. Jernigan DB, Sanders LI, Waites KB et al. Pulmonary infection due to Legionella cincinnatiensis in renal transplant recipients, two cases and implications for laboratory diagnosis. Clin Infect Dis 1994; 18: 385-389.
20. Singh N, Muder RR, Yu VL, Gayowski T. Legionella infection in liver transplant recipients: implications for management. Transplantation 1993; 56: 1549-1551.
21. Skerrett SJ, Schmidt RA, Martin TR. Impaired clearance of aerosolized Legionella pneumophila in corticosteroid-treated rats: a model of Legionnaires' disease in the compromised host. J Infect Dis 1989; 160: 261-273.
22. Wilkinson HW. Identifying Legionella species and serogroups by immunofluorescence staining. In: Hospital Laboratory Diagnosis of Legionella Infections. Centers for Disease Control: Atlanta, 1987, pp 13-15.
23. Winn WC. Legionella and the clinical microbiologist. Infect Dis Clin N Am 1993; 7: 377-392.
24. Wilkinson IJ, Sangster N, Ratcliff RM et al. Problems associated with identification of Legionella species from the environment and isolation of six possible new species. Appl Environ Micmbiol 1990; 56: 796-802.
25. Winn WC. Legionnaires' disease: historical perspective. Clin Microbiol Rev 1988; 1: 60-81.
26. Muder RR, Yu VL, Zuravleff JJ. Pneumonia due to the Pittsburgh pneumonia agent: new clinical perspective with a review of the literature. Medicine 1983; 62: 120-128.
27. Fang G-D, Yu VL, Vickers RM. Disease due to Legionellaceae (other than Legionella pneumophila): historical, microbiological, clinical and epidemiological review. Medicine 1989; 68: 116-132.
28. Dowling JN, Saha AK, Glew RH. Virulence factors of the family Legionellaceae. Microbiol Rev 1992; 56: 32-60.
29. Blanchard DI, Friedman H, Klein TW, Djen JY. Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukocyte Biol 1989; 45: 538-545.
30. Blanchard DK, Djen JY, Klein TW et al. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukocyte Biol 1988; 43: 429-435.
31. Davis GS, Winn WC, Gump DW, Beaty HN. The kinetics of early inflammatory events during experimental pneumonia due to Legionella pneumophila in guinea pigs. J Infect Dis 1983; 148: 823-835.
32. Fitzgeorge RB, Featherstone ASR, Baskerville A. Effects of polymorphonuclear leukocyte depletion on the pathogenesis of experimental Legionnaires' disease. Br J Exp Path 1988; 69: 105-112.
33. Nikaido Y, Yoshida S-I, Goto Y et al. Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs. Infect Immunity 1989; 57: 3458-3465.
34. Friedman H, Widen R, Lee I, Klein T. Cellular immunity to Legionella pneumophila in guinea pigs assessed by direct and indirect migration inhibition in vitro. Infect Immunity 1983; 41: 1132-1137.
35. Horwitz MA, Silverstein SC. Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria. J Exp Med 1981; 154: 1618-1635.
36. Nash TW, Libby DM, Horwitz MA. Interaction between the Legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influences of antibody, lymphokines, and hydrocortisone. J Clin Invest 1984; 74: 771-782.
37. Bhardwaj N, Nash TW, Horwitz MA. Interferon-γ-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. J Immunol 1986; 137: 2662-2669.
38. Nash TW, Libby DM, Horwitz MA. IFN-γ-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol 1988; 140: 3978-3981.
39. Skerrett SJ, Martin TR. Alveolar macrophage activation in experimental Legionellosis. J Immunol 1991; 147: 337-345.
40. Gump DW, Frank RO, Winn WC et al. Legionnaires' disease in patients with associated serious disease. Ann Intern Med 1979; 90: 538-542.
41. Muder RR, Yu VL, Parry MF. The radiologic manifestations of Legionella pneumonia. Semin Resp Infect 1987; 2: 242-254.
42. Crawford SW, Hackman RC, Clark JG. Biopsy diagnosis and clinical outcome of persistent focal pulmonary lesions after marrow transplantation. Transplantation 1989; 48: 266-271.
43. Zuravleff JJ, Yu VL, Shonnard JW et al. Diagnosis of Legionnaires' disease: an update of laboratory methods with new emphasis on isolation by culture. JAMA 1983; 250: 1981-1985.
44. Edelstein PH. Legionnaires' disease. Clin Infect Dis 1993; 16: 741-749.
45. Koide M, Saito A. Diagnosis of Legionella pneumophila infection by polymerase chain reaction. Clin Infect Dis 1995; 21: 199-201.
46. Meyer RD. Role of quinolones in the treatment of Legionellosis. J Antimicrobial Chemother 1991; 28: 623-625.
47. Hamedani P, Ali J, Hafeez S et al. The safety and efficacy of clarithromycin in patients with Legionella pneumonia. Chest 1991; 100: 1503-1506.